Monday, February 16, 2026 2/16/2026

Developing a validated biomarker of cortical neurodegeneration in Alzheimer's disease using high-gradient diffusion MRI

Award Number: R21AG085795
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2024
PERIOD OF PERFORMANCE END DATE: 01/31/2027

Group Awards By:

View Award Description

Developing a validated biomarker of cortical neurodegeneration in Alzheimer's disease using high-gradient diffusion MRI - SUMMARY The pathological changes of Alzheimer’s disease (AD) develop long before the onset of symptoms, with the gradual accumulation of amyloid and tau in the brain followed by neuronal loss. While macroscopic brain changes such as hippocampal atrophy and cortical thinning are well-established as markers of symptomatic AD, the predictive value of such structural imaging measures is limited prior to the onset of dementia. High-gradient diffusion MRI has emerged as a sensitive tool for probing microstructural alterations throughout the whole brain and holds great promise for capturing the earliest microscopic gray matter abnormalities present in AD, before their overt manifestation on conventional MRI. With the recent introduction of commercially available high- performance gradient systems for clinical research, further elucidation of these imaging findings across the AD spectrum and systematic comparison against histopathology is timely and critical for gaining a better understanding of neuronal degeneration and the pathogenic factors influencing disease progression. The goal of this project is to leverage the sensitivity of high-gradient diffusion MRI to map alterations in gray matter microstructure in patients with mild cognitive impairment (MCI)/AD and individuals at risk of developing AD. This work will build on the hardware and acquisition advances that our group has worked on for over a decade as part of the Human Connectome Project and BRAIN Initiative to push the limits of diffusion MRI for mapping brain tissue microstructure in the living human brain. We propose to acquire advanced diffusion MRI measures on the next-generation Connectome scanner to map cortical and white matter microstructure in MCI/AD patients from the Massachusetts General Hospital Alzheimer’s Disease Research Center (MADRC) and individuals from the Human Connectome Project-Lifespan/Aging (HCP-Aging) cohort. Aim 1 will assess the relationship between cortical microstructural metrics obtained from high-gradient diffusion MRI and amyloid and tau PET uptake in MCI/AD and cognitively healthy older adults. Aim 2 will validate diffusion MRI measures of cellular morphology against histopathology performed in vulnerable regions of postmortem brain specimens obtained from patients with pathology-proven AD. At the end of this project, we anticipate the development of a validated, multi-scale advanced diffusion MRI protocol targeted for evaluating alterations in cortical microstructure in older adults of differing AD pathology status, with clear measures that can be translated to large-scale AD studies. Such information will inform the interpretation of diffusion imaging metrics acquired using commercially available MRI scanner hardware and provide key information regarding the underlying disease evolution to aid in the development of future neuroprotective therapies for AD.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	THE GENERAL HOSPITAL CORPORATION	55 FRUIT ST	BOSTON	MA	02114	SUFFOLK	USA	Aging Research	000	2	12/1/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $208,750 )
2025	2025	THE GENERAL HOSPITAL CORPORATION	55 FRUIT ST	BOSTON	MA	02114	SUFFOLK	USA	Aging Research	001	2	4/28/2025	NON-COMPETING CONTINUATION	$20,875
2025	2025	THE GENERAL HOSPITAL CORPORATION	55 FRUIT ST	BOSTON	MA	02114	SUFFOLK	USA	Aging Research	000	2	3/6/2025	NON-COMPETING CONTINUATION	$187,875
														Subtotal = $208,750

Issue Date FY: 2024 ( Subtotal = $250,500 )
2024	2024	THE GENERAL HOSPITAL CORPORATION	55 FRUIT ST	BOSTON	MA	02114	SUFFOLK	USA	Aging Research	000	1	1/30/2024	NEW	$250,500
														Subtotal = $250,500

Grand Total All Awards = $459,250

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Developing a validated biomarker of cortical neurodegeneration in Alzheimer's disease using high-gradient diffusion MRI

Award Number: R21AG085795

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2024

PERIOD OF PERFORMANCE END DATE: 01/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer